A number of global molecular diagnostics companies, ranging from independent labs and major participants to smaller firms, have developed or are in the process of developing COVID-19 molecular diagnostic tests. While this virus has played havoc across a plethora of companies, molecular diagnostics has emerged as the bright spot in an otherwise dark scenario. To give credit where it is due, the companies in this sector have stepped up and responded to the crisis by unveiling tests to detect the SARS-CoV-2 virus, the dividends of which are paying off now. This world market compendium by the publisher analyzes the market for Molecular Diagnostics at a high level by technology, product type, application, end-use facility, and geographic region. The market is studied for historical/current trends and future forecast in terms of value in US$ for 2019, 2022, and 2026.
Technologies
- Polymerase Chain Reaction (PCR)
- Sequencing
- Hybridization
- Other
Products
- Reagents and Consumables
- Instruments
- Software and Services
Applications
- Infectious Diseases
- Oncology
- Blood Testing
- Genetic Testing
- Prenatal Testing
- Other
End-Use Facility
- Hospitals & Diagnostics Labs
- Research Institutes & Universities
- Other
Geographic Regions
- North America
- Europe
- Asia-Pacific
- Rest of World
This report provides estimates and forecasts for the global Molecular Diagnostics market. The study also provides the key market developments and a list of major players in this market that are cited.
Table of Contents
Companies Mentioned
- Abbott Diagnostics
- Agendia NV
- Agilent Technologies, Inc.
- Becton, Dickinson and Company
- Biomérieux SA
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Dna Diagnostics Center
- Elitechgroup
- Exact Sciences Corporation
- F. Hoffmann-La Roche AG
- Genmark Diagnostics, Inc.
- Global Life Sciences Solutions USA LLC (Cytiva)
- Grifols International, S.A.
- Hologic, Inc.
- Illumina, Inc.
- Kaneka Eurogentec S.A.
- Laboratory Corporation Of America® Holdings
- Luminex Corporation
- Merck KGaA (Merck Millipore)
- Myriad Genetics, Inc.
- Origene Technologies, Inc.
- Ortho Clinical Diagnostics
- Oxford Gene Technology
- Perkinelmer Inc.
- Promega Corporation
- Qiagen N.V.
- Savyon Diagnostics
- Seegene Inc.
- Iemens Healthcare GmbH
- Sorenson Genomics, LLC
- Sysmex Inostics GmbH
- Thermo Fisher Scientific Inc.
- Transgenomic Inc.
- Wuxi Nextcode
